The coronavirus pandemic in the United States is not waning. On the contrary, the rapid spread of the highly-contagious Delta variant has forced policymakers and public health officials alike to look into vaccine booster shots.
On Friday, advisers to the Food and Drug Administration (FDA) voted 16-2 against approving booster shots of the Pfizer vaccine for Americans older than 16.
After that, the panel voted unanimously to approve Pfizer boosters in Americans 65 and older and those at high risk of developing severe COVID-19 symptoms, as reported by CNN.
Read more below.